484 related articles for article (PubMed ID: 18040614)
1. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
Krengli M; Loi G; Sacchetti G; Manfredda I; Gambaro G; Brambilla M; Carriero A; Inglese E
Strahlenther Onkol; 2007 Dec; 183(12):689-94. PubMed ID: 18040614
[TBL] [Abstract][Full Text] [Related]
2. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas.
Grosu AL; Weber W; Feldmann HJ; Wuttke B; Bartenstein P; Gross MW; Lumenta C; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):517-26. PubMed ID: 10802381
[TBL] [Abstract][Full Text] [Related]
3. On M. Krengli, G. Loi, G. Sacchetti et al. Delineation of Target Volume for Radiotherapy of High-Grade Gliomas by (99)mTc-MIBI SPECT and MRI Fusion in: Strahlenther Onkol 2007;183:689-94 (No. 12).
Alexiou GA; Tsiouris S; Voulgaris S; Polyzoidis KS; Kyritsis AP; Fotopoulos AD
Strahlenther Onkol; 2008 Jun; 184(6):332-3. PubMed ID: 18535810
[No Abstract] [Full Text] [Related]
4. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
6. Attenuation-corrected 99mTc-MIBI SPECT in overweight patients with chronic ischaemic dysfunction: a comparison to NH3 PET and implications for the diagnosis of myocardial viability.
Roelants V; Bernard X; Walrand S; Bol A; Coppens A; Jamart J; Melin J; Vanoverschelde JL
Nucl Med Commun; 2006 Oct; 27(10):815-21. PubMed ID: 16969265
[TBL] [Abstract][Full Text] [Related]
7. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
[TBL] [Abstract][Full Text] [Related]
8. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
9. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
10. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
11. [Proton magnetic resonance spectroscopic imaging and other types of metabolic imaging for radiotherapy planning in adult and pediatric high-grade gliomas].
Laprie A
Cancer Radiother; 2009 Oct; 13(6-7):556-61. PubMed ID: 19766525
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction.
Ibrahim T; Bülow HP; Hackl T; Hörnke M; Nekolla SG; Breuer M; Schömig A; Schwaiger M
J Am Coll Cardiol; 2007 Jan; 49(2):208-16. PubMed ID: 17222732
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
[TBL] [Abstract][Full Text] [Related]
15. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
Neumann DR; Obuchowski NA; Difilippo FP
J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
[TBL] [Abstract][Full Text] [Related]
16. [Image registration for radiation therapy: Practical aspects and quality control].
Bonniaud G; Isambert A; Dhermain F; Beaudré A; Ferreira I; Ricard M; Lefkopoulos D
Cancer Radiother; 2006 Sep; 10(5):222-30. PubMed ID: 16890471
[TBL] [Abstract][Full Text] [Related]
17. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
18. Correlation of clinical, MRI and Tc-99m HMPAO SPECT findings in neuro-Behçet's disease.
Cengiz N; Sahin M; Onar M
Acta Neurol Belg; 2004 Sep; 104(3):100-5. PubMed ID: 15508262
[TBL] [Abstract][Full Text] [Related]
19. Assessment of radiotherapeutic effect on brain tumors by dynamic susceptibility contrast MR imaging: a preliminary report.
Tomoi M; Maeda M; Yoshida M; Yamada H; Kawamura Y; Hayashi N; Ishii Y; Kubota T
Radiat Med; 1999; 17(3):195-9. PubMed ID: 10440107
[TBL] [Abstract][Full Text] [Related]
20. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis.
Ingui CJ; Shah NP; Oates ME
Clin Nucl Med; 2006 Nov; 31(11):665-72. PubMed ID: 17053381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
